Zoetis, Inc. (ZTS)
77.10
-0.63
(-0.81%)
USD |
NYSE |
Aug 24, 16:00
77.45
+0.35
(+0.45%)
After-Hours: 20:00
Zoetis Shareholders Equity (Quarterly) : 3.148B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.148B |
| March 31, 2026 | 3.233B |
| December 31, 2025 | 3.331B |
| September 30, 2025 | 5.398B |
| June 30, 2025 | 4.977B |
| March 31, 2025 | 4.655B |
| December 31, 2024 | 4.77B |
| September 30, 2024 | 5.234B |
| June 30, 2024 | 4.966B |
| March 31, 2024 | 5.058B |
| December 31, 2023 | 4.997B |
| September 30, 2023 | 5.078B |
| June 30, 2023 | 4.625B |
| March 31, 2023 | 4.494B |
| December 31, 2022 | 4.405B |
| September 30, 2022 | 4.663B |
| June 30, 2022 | 4.58B |
| March 31, 2022 | 4.658B |
| December 31, 2021 | 4.543B |
| September 30, 2021 | 4.679B |
| June 30, 2021 | 4.35B |
| March 31, 2021 | 4.089B |
| December 31, 2020 | 3.769B |
| September 30, 2020 | 3.602B |
| June 30, 2020 | 2.982B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.753B |
| December 31, 2019 | 2.708B |
| September 30, 2019 | 2.678B |
| June 30, 2019 | 2.411B |
| March 31, 2019 | 2.317B |
| December 31, 2018 | 2.185B |
| September 30, 2018 | 2.118B |
| June 30, 2018 | 1.97B |
| March 31, 2018 | 1.96B |
| December 31, 2017 | 1.77B |
| September 30, 2017 | 1.989B |
| June 30, 2017 | 1.715B |
| March 31, 2017 | 1.609B |
| December 31, 2016 | 1.487B |
| September 30, 2016 | 1.585B |
| June 30, 2016 | 1.357B |
| March 31, 2016 | 1.165B |
| December 31, 2015 | 1.068B |
| September 30, 2015 | 1.229B |
| June 30, 2015 | 1.176B |
| March 31, 2015 | 1.278B |
| December 31, 2014 | 1.311B |
| September 30, 2014 | 1.364B |
| June 30, 2014 | 1.26B |
| March 31, 2014 | 1.077B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 41.93B |
| Elanco Animal Health, Inc. | 6.588B |
| Boston Scientific Corp. | 24.93B |
| Pfizer Inc. | 85.19B |
| Phibro Animal Health Corp. | 361.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.08B |
| Total Liabilities (Quarterly) | 11.93B |
| Debt to Equity Ratio | 2.935 |
| Current Ratio | 3.084 |
| Net Debt Paydown Yield | -1.67% |